Yizheng Zu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yizheng Zu has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Jianying Yan
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital
2 shared publications - Jianying Yan
College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital
2 shared publications Xia Xu
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, China
2 shared publications- Xia Xu
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University Fujian Maternity and Child Health Hospital, Fuzhou, PR China
2 shared publications - Xiaoyan Xiu
Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China
2 shared publications Yi Xie
Fujian Maternity and Child Health Hospital, 350001 Fuzhou, Fujian, China
2 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-27
Trends and Frontiers in Stem Cell Research for Sepsis: A Bibliometric Analysis (1990–2025)
Purpose: To systematically map the 35-year intellectual evolution of stem cell research in sepsis and identify emerging frontiers for clinical translation. Methods: We retrieved 3890 publications (1990– 2025) from the Web of Science Core Collection. Multi-dimensional bibliometric analyses, including co-citation networks, keyword bursts, and alluvial flow mapping, were performed using CiteSpace, HistCite, and R to delineate the field’s trajectory. Results: Annual publications increased significantly, peaking in 2024, with the USA and China as primary contributors. The research focus has undergone a major paradigm shift: from early "bone marrow transplantation” and hematopoietic reconstitution (1990s– 2000s) to the immunomodulatory mechanisms of "mesenchymal stem cells” (2010s). Currently, the field has entered a "cell-free” era, characterized by intense research into "extracellular vesicles” and "exosomes” (2021– 2025). Alluvial analysis identified "cancer”, "immunotherapy”, and "COVID-19” as dominant integrated modules. Notably, the emergence of "guidelines” and "precision care” highlights a growing emphasis on clinical standardization and targeted treatment for sepsis-induced organ failure. Conclusion: This study demonstrates that the frontier of sepsis therapy is moving toward refined, secretome-based biologics. Our findings provide a strategic roadmap for researchers to prioritize high-potential therapeutic targets and for clinicians to design more focused trials, ultimately accelerating the integration of stem cell-derived products into mainstream sepsis management.
- 1 November 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-27
Open AccessTrends and Frontiers in Stem Cell Research for Sepsis: A Bibliometric Analysis (1990–2025)
Purpose: To systematically map the 35-year intellectual evolution of stem cell research in sepsis and identify emerging frontiers for clinical translation. Methods: We retrieved 3890 publications (1990– 2025) from the Web of Science Core Collection. Multi-dimensional bibliometric analyses, including co-citation networks, keyword bursts, and alluvial flow mapping, were performed using CiteSpace, HistCite, and R to delineate the field’s trajectory. Results: Annual publications increased significantly, peaking in 2024, with the USA and China as primary contributors. The research focus has undergone a major paradigm shift: from early "bone marrow transplantation” and hematopoietic reconstitution (1990s– 2000s) to the immunomodulatory mechanisms of "mesenchymal stem cells” (2010s). Currently, the field has entered a "cell-free” era, characterized by intense research into "extracellular vesicles” and "exosomes” (2021– 2025). Alluvial analysis identified "cancer”, "immunotherapy”, and "COVID-19” as dominant integrated modules. Notably, the emergence of "guidelines” and "precision care” highlights a growing emphasis on clinical standardization and targeted treatment for sepsis-induced organ failure. Conclusion: This study demonstrates that the frontier of sepsis therapy is moving toward refined, secretome-based biologics. Our findings provide a strategic roadmap for researchers to prioritize high-potential therapeutic targets and for clinicians to design more focused trials, ultimately accelerating the integration of stem cell-derived products into mainstream sepsis management.
- Open Access
- 28 August 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1915090
Higher dietary phytochemical index is associated with lower risk of epithelial ovarian cancer in Chinese women: a case–control study
Background: Dietary phytochemicals have been suggested to play a protective role against cancer development. This study aimed to examine the association between dietary phytochemical index (DPI) and epithelial ovarian cancer (EOC) risk among Chinese women. Methods: In this retrospective case–control study, 500 women (250 newly diagnosed EOC patients and 250 cancer-free participants) were included. Dietary intake was assessed using a validated food frequency questionnaire (FFQ), and DPI was calculated as the percentage of energy derived from phytochemical-rich foods. Multivariable logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between DPI and EOC risk. Results: Higher DPI was significantly associated with lower odds of EOC. Each one-unit increase in DPI was linked to a reduced risk in both crude and adjusted models (fully adjusted OR: 0.90; 95% CI: 0.81–0.99). Participants in the highest DPI tertile had a 31% lower odds of EOC compared to those in the lowest tertile (OR: 0.69; 95% CI: 0.49–0.96). The inverse association was more pronounced among overweight/obese women ( P for interaction = 0.041). Conclusion: Greater adherence to a phytochemical-rich diet may be associated with reduced risk of EOC. Prospective studies are warranted to confirm these findings.
- 28 August 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1915090
Open AccessHigher dietary phytochemical index is associated with lower risk of epithelial ovarian cancer in Chinese women: a case–control study
Background: Dietary phytochemicals have been suggested to play a protective role against cancer development. This study aimed to examine the association between dietary phytochemical index (DPI) and epithelial ovarian cancer (EOC) risk among Chinese women. Methods: In this retrospective case–control study, 500 women (250 newly diagnosed EOC patients and 250 cancer-free participants) were included. Dietary intake was assessed using a validated food frequency questionnaire (FFQ), and DPI was calculated as the percentage of energy derived from phytochemical-rich foods. Multivariable logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between DPI and EOC risk. Results: Higher DPI was significantly associated with lower odds of EOC. Each one-unit increase in DPI was linked to a reduced risk in both crude and adjusted models (fully adjusted OR: 0.90; 95% CI: 0.81–0.99). Participants in the highest DPI tertile had a 31% lower odds of EOC compared to those in the lowest tertile (OR: 0.69; 95% CI: 0.49–0.96). The inverse association was more pronounced among overweight/obese women ( P for interaction = 0.041). Conclusion: Greater adherence to a phytochemical-rich diet may be associated with reduced risk of EOC. Prospective studies are warranted to confirm these findings.
- Open Access
- 9 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (2) , e46002
Immune cell signatures and preeclampsia: Unveiling causal links through genome-wide association studies
The immune-placental interaction could potentially contribute both causally and therapeutically to preeclampsia (PE). However, previous observational studies have not demonstrated a causal association between these 2 factors. Exploring the causal relationship between immune cells and PE provides genetic evidence that immune cells play a role in PE risk. Using a large dataset of genome-wide association studies, we conducted a bidirectional Mendelian randomization (MR) analysis to determine whether 731 immune cell signatures were correlated with PE, which included 4 types of immune signatures. After false discovery rate (FDR) correction, 3 immunophenotypes were identified to be significantly associated with PE risk: human leukocyte antigen on dendritic cells (odds ratio [OR] = 1.072, 95% confidence interval [CI] = 1.0352–1.110, P FDR = .012), absolute T cell count (OR = 1.477, 95% CI = 1.281–1.703, P FDR = 1.71 × 10 −5 ), and absolute lymphocyte count (OR = 1.514, 95% CI = 1.306–1.755, P FDR = 1.58 × 10 −5 ). Furthermore, PE did not affect immunophenotypes significantly after FDR adjustment, but 12 suggestive immunophenotypes were detected without FDR adjustment, including CD3 on activated and secreting CD4 regulatory T cell ( β = 0.467, P = .039), CD3 on CD39 + CD4 + T cell ( β = 0.508, P = .024), CD3 on CD45RA + CD4 + T cell ( β = 0.515, P = .022), CD3 on CD28 + CD45RA + CD8 + T cell ( β = 0.494, P = .028), CD3 on CD39 + CD8 + T cell ( β = 0.486, P = .029), CD45 on HLA DR + CD8 + T cell ( β = 0.518, P = .018), CD3 on secreting CD4 regulatory T cell ( β = 0.508, P = .025), CD25 on resting CD4 regulatory T cell ( β = 0.496, P = .018), CD4 on CD39 + activated CD4 regulatory T cell ( β = 0.445, P = .048), CD3 on CD28 + CD45RA − CD8 + T cell ( β = 0.498, P = .024), CD3 on effector memory CD4 + T cell ( β = 0.614, P = .007), and CD3 on activated CD4 regulatory T cell( β = 0.444, P = .049). Using genetic methods, this study uncovers the close relationship between immune cells and PE, which provides guidance for future clinical trials.
- 9 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (2) , e46002
Open AccessImmune cell signatures and preeclampsia: Unveiling causal links through genome-wide association studies
The immune-placental interaction could potentially contribute both causally and therapeutically to preeclampsia (PE). However, previous observational studies have not demonstrated a causal association between these 2 factors. Exploring the causal relationship between immune cells and PE provides genetic evidence that immune cells play a role in PE risk. Using a large dataset of genome-wide association studies, we conducted a bidirectional Mendelian randomization (MR) analysis to determine whether 731 immune cell signatures were correlated with PE, which included 4 types of immune signatures. After false discovery rate (FDR) correction, 3 immunophenotypes were identified to be significantly associated with PE risk: human leukocyte antigen on dendritic cells (odds ratio [OR] = 1.072, 95% confidence interval [CI] = 1.0352–1.110, P FDR = .012), absolute T cell count (OR = 1.477, 95% CI = 1.281–1.703, P FDR = 1.71 × 10 −5 ), and absolute lymphocyte count (OR = 1.514, 95% CI = 1.306–1.755, P FDR = 1.58 × 10 −5 ). Furthermore, PE did not affect immunophenotypes significantly after FDR adjustment, but 12 suggestive immunophenotypes were detected without FDR adjustment, including CD3 on activated and secreting CD4 regulatory T cell ( β = 0.467, P = .039), CD3 on CD39 + CD4 + T cell ( β = 0.508, P = .024), CD3 on CD45RA + CD4 + T cell ( β = 0.515, P = .022), CD3 on CD28 + CD45RA + CD8 + T cell ( β = 0.494, P = .028), CD3 on CD39 + CD8 + T cell ( β = 0.486, P = .029), CD45 on HLA DR + CD8 + T cell ( β = 0.518, P = .018), CD3 on secreting CD4 regulatory T cell ( β = 0.508, P = .025), CD25 on resting CD4 regulatory T cell ( β = 0.496, P = .018), CD4 on CD39 + activated CD4 regulatory T cell ( β = 0.445, P = .048), CD3 on CD28 + CD45RA − CD8 + T cell ( β = 0.498, P = .024), CD3 on effector memory CD4 + T cell ( β = 0.614, P = .007), and CD3 on activated CD4 regulatory T cell( β = 0.444, P = .049). Using genetic methods, this study uncovers the close relationship between immune cells and PE, which provides guidance for future clinical trials.
- Open Access
- 12 December 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1682007
The role of gut microbiota imbalance in preeclampsia pathogenesis: insights into FMO3-mediated inflammatory mechanisms
Background: Preeclampsia (PE) is a severe pregnancy complication linked to systemic inflammation and metabolic dysregulation. Emerging evidence suggests gut microbiota imbalance may contribute to PE pathogenesis, but the underlying mechanisms remain unclear. This study investigated whether gut dysbiosis triggers PE through flavin-containing monooxygenase 3 (FMO3)-mediated inflammatory pathways. Methods: We transplanted fecal microbiota from PE rats, healthy pregnant (HP) rats, and non-pregnant (NP) rats into antibiotic-treated dysbiotic rats, with a control group receiving normal saline (CON). Additionally, FMO3 expression was inhibited using FMO3-RNAi in parallel groups. We measured blood pressure, urine protein, FMO3 protein and mRNA expression, inflammatory markers, liver and kidney function, embryo resorption rate, and fetal weight. Gut microbiota composition was analyzed by 16S rRNA gene sequencing. The impact of interleukin-8 (IL-8) on trophoblast cell function was assessed using cell counting kit-8 (CCK-8), transwell invasion, and tube formation assays. Results: Rats receiving PE fecal microbiota transplantation (FMT) exhibited a gradual rise in blood pressure post-pregnancy, varying degrees of liver and kidney damage, markedly elevated serum inflammatory cytokines, higher fetal resorption rates, and reduced placental weights. FMO3 protein and mRNA expressions were significantly higher in the PE-FMT group. FMO3 knockdown partially improved these perinatal outcomes. Antibiotic treatment significantly decreased gut microbiota alpha and beta diversity. At the genus level, the PE-FMO3-RNAi group showed increased Escherichia-Shigella and decreased Lactobacillus compared to the PE-CON-RNAi group. In cell experiments, elevated IL-8 levels decreased the viability and invasiveness of HTR-8/SVneo cells and diminished the angiogenic potential of human umbilical vein endothelial cells (HUVECs). Conclusion: A disruption of gut microbiota could result in PE through the FMO3-driven inflammatory response, and targeting FMO3 may prove valuable in treating PE.
- 12 December 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1682007
Open AccessThe role of gut microbiota imbalance in preeclampsia pathogenesis: insights into FMO3-mediated inflammatory mechanisms
Background: Preeclampsia (PE) is a severe pregnancy complication linked to systemic inflammation and metabolic dysregulation. Emerging evidence suggests gut microbiota imbalance may contribute to PE pathogenesis, but the underlying mechanisms remain unclear. This study investigated whether gut dysbiosis triggers PE through flavin-containing monooxygenase 3 (FMO3)-mediated inflammatory pathways. Methods: We transplanted fecal microbiota from PE rats, healthy pregnant (HP) rats, and non-pregnant (NP) rats into antibiotic-treated dysbiotic rats, with a control group receiving normal saline (CON). Additionally, FMO3 expression was inhibited using FMO3-RNAi in parallel groups. We measured blood pressure, urine protein, FMO3 protein and mRNA expression, inflammatory markers, liver and kidney function, embryo resorption rate, and fetal weight. Gut microbiota composition was analyzed by 16S rRNA gene sequencing. The impact of interleukin-8 (IL-8) on trophoblast cell function was assessed using cell counting kit-8 (CCK-8), transwell invasion, and tube formation assays. Results: Rats receiving PE fecal microbiota transplantation (FMT) exhibited a gradual rise in blood pressure post-pregnancy, varying degrees of liver and kidney damage, markedly elevated serum inflammatory cytokines, higher fetal resorption rates, and reduced placental weights. FMO3 protein and mRNA expressions were significantly higher in the PE-FMT group. FMO3 knockdown partially improved these perinatal outcomes. Antibiotic treatment significantly decreased gut microbiota alpha and beta diversity. At the genus level, the PE-FMO3-RNAi group showed increased Escherichia-Shigella and decreased Lactobacillus compared to the PE-CON-RNAi group. In cell experiments, elevated IL-8 levels decreased the viability and invasiveness of HTR-8/SVneo cells and diminished the angiogenic potential of human umbilical vein endothelial cells (HUVECs). Conclusion: A disruption of gut microbiota could result in PE through the FMO3-driven inflammatory response, and targeting FMO3 may prove valuable in treating PE.
- Open Access
- 1 August 2025
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 18, 4195-4207
A Multi-Algorithm Machine Learning Model for Predicting the Risk of Preterm Birth in Patients with Early-Onset Preeclampsia
Purpose: To analyze the risk factors for preterm birth in patients with early-onset preeclampsia (EOPE) based on multi-algorithm machine learning and to construct a predictive model to explore the predictive value of the model. Methods: A retrospective analysis was conducted on 442 EOPE patients from a single tertiary center, divided into preterm birth (< 37 weeks, n=358) and term-born (≥ 37 weeks, n=84) groups. Univariate analysis, random forest importance assessment, lasso regression combined with multivariate regression analysis were used for feature evaluation. Eight machine learning models were trained (70% data) and validated (30% data). A Stacking ensemble model was constructed, and SHapley Additive exPlanations (SHAP) was used for feature interpretation. Results: The area under the receiver operating characteristic curve (AUROC) for predicting preterm birth in EOPE patients using Logistic Regression, Gaussian Naive Bayes, Extreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine, Support Vector Machine (SVM), Gradient Boosting Decision Tree (GBDT), Multi-Layer Perceptron, and Elastic Net were 0.763, 0.712, 0.821, 0.832, 0.821, 0.842, 0.784, and 0.763, respectively. The Stacking model (XGBoost+GBDT+SVM) achieved superior performance (AUROC=0.865). Three independent risk factors were identified: fetal growth restriction (aOR=3.50, p = 0.047), serum cystatin C (aOR=11.27, p = 0.018), and C-reactive protein (aOR=1.37, p < 0.001). SHAP analysis revealed GBDT as the top contributor to Stacking predictions, with microalbunminuria (GBDT, XGBoost) and age (SVM) being the most influential features. Conclusion: Machine learning models can serve as reliable assessment tools for predicting the risk of preterm birth in patients with EOPE. The ensemble prediction model demonstrates the best predictive performance, helping obstetricians identify high-risk patients and perform early intervention to improve perinatal outcomes.
- 1 August 2025
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 18, 4195-4207
Open AccessA Multi-Algorithm Machine Learning Model for Predicting the Risk of Preterm Birth in Patients with Early-Onset Preeclampsia
Purpose: To analyze the risk factors for preterm birth in patients with early-onset preeclampsia (EOPE) based on multi-algorithm machine learning and to construct a predictive model to explore the predictive value of the model. Methods: A retrospective analysis was conducted on 442 EOPE patients from a single tertiary center, divided into preterm birth (< 37 weeks, n=358) and term-born (≥ 37 weeks, n=84) groups. Univariate analysis, random forest importance assessment, lasso regression combined with multivariate regression analysis were used for feature evaluation. Eight machine learning models were trained (70% data) and validated (30% data). A Stacking ensemble model was constructed, and SHapley Additive exPlanations (SHAP) was used for feature interpretation. Results: The area under the receiver operating characteristic curve (AUROC) for predicting preterm birth in EOPE patients using Logistic Regression, Gaussian Naive Bayes, Extreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine, Support Vector Machine (SVM), Gradient Boosting Decision Tree (GBDT), Multi-Layer Perceptron, and Elastic Net were 0.763, 0.712, 0.821, 0.832, 0.821, 0.842, 0.784, and 0.763, respectively. The Stacking model (XGBoost+GBDT+SVM) achieved superior performance (AUROC=0.865). Three independent risk factors were identified: fetal growth restriction (aOR=3.50, p = 0.047), serum cystatin C (aOR=11.27, p = 0.018), and C-reactive protein (aOR=1.37, p < 0.001). SHAP analysis revealed GBDT as the top contributor to Stacking predictions, with microalbunminuria (GBDT, XGBoost) and age (SVM) being the most influential features. Conclusion: Machine learning models can serve as reliable assessment tools for predicting the risk of preterm birth in patients with EOPE. The ensemble prediction model demonstrates the best predictive performance, helping obstetricians identify high-risk patients and perform early intervention to improve perinatal outcomes.
- Open Access
- 5 March 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (3) , 26808
Investigating the Link Between Poor Sleep Patterns and Type 2 Diabetes Mellitus in Women With a History of Gestational Diabetes Mellitus: A Retrospective Population-Based Study
Background: This study aimed in this study was to investigate the association between poor sleep patterns (PSPs) and type 2 diabetes mellitus (T2DM) in women with a history of gestational diabetes mellitus (GDM). Methods: Our analysis was based on a population-based sample from National Health and Nutrition Examination Survey (NHANES) data collected between 2007 and 2018. The association between PSPs and T2DM in women with a history of GDM was assessed using logistic regression models. We performed subgroup analyses stratified by age, body mass index (BMI), race, educational level, moderate recreational activities, smoking behavior, and parity. Results: A total of 917 women with a history of GDM were included in our study. Compared to the non-PSPs group, participants with PSPs had a higher possibility for T2DM in women with a history of GDM (odds ratio (OR) = 2.37, 95% confidence interval (CI): 1.45–3.86). Furthermore, this association was more prominent in those aged between 35 and 49 (OR = 2.20, 95% CI: 1.03–4.71), a BMI ≥30 kg/m2 (OR = 2.56, 95% CI: 1.43–4.60), non-Hispanic white (OR = 5.34, 95% CI: 2.09–13.66) or non-Hispanic black (OR = 5.02, 95% CI: 1.48–17.06), educated beyond high school (OR = 2.65, 95% CI: 1.35–5.23), not engaged in moderate recreational activities (OR = 3.25, 95% CI: 1.72–6.14) groups and parity ≥4 (OR = 2.62, 95% CI: 1.03–6.63). Conclusions: Our findings suggest that PSPs are positively associated with the prevalence of T2DM in women with a history of GDM, which demonstrates that we need targeted interventions, especially for those at high risk. Future research should evaluate how sleep patterns affect metabolic health and develop new ways to lower the risk of T2DM in women with a history of GDM.
- 5 March 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (3) , 26808
Open AccessInvestigating the Link Between Poor Sleep Patterns and Type 2 Diabetes Mellitus in Women With a History of Gestational Diabetes Mellitus: A Retrospective Population-Based Study
Background: This study aimed in this study was to investigate the association between poor sleep patterns (PSPs) and type 2 diabetes mellitus (T2DM) in women with a history of gestational diabetes mellitus (GDM). Methods: Our analysis was based on a population-based sample from National Health and Nutrition Examination Survey (NHANES) data collected between 2007 and 2018. The association between PSPs and T2DM in women with a history of GDM was assessed using logistic regression models. We performed subgroup analyses stratified by age, body mass index (BMI), race, educational level, moderate recreational activities, smoking behavior, and parity. Results: A total of 917 women with a history of GDM were included in our study. Compared to the non-PSPs group, participants with PSPs had a higher possibility for T2DM in women with a history of GDM (odds ratio (OR) = 2.37, 95% confidence interval (CI): 1.45–3.86). Furthermore, this association was more prominent in those aged between 35 and 49 (OR = 2.20, 95% CI: 1.03–4.71), a BMI ≥30 kg/m2 (OR = 2.56, 95% CI: 1.43–4.60), non-Hispanic white (OR = 5.34, 95% CI: 2.09–13.66) or non-Hispanic black (OR = 5.02, 95% CI: 1.48–17.06), educated beyond high school (OR = 2.65, 95% CI: 1.35–5.23), not engaged in moderate recreational activities (OR = 3.25, 95% CI: 1.72–6.14) groups and parity ≥4 (OR = 2.62, 95% CI: 1.03–6.63). Conclusions: Our findings suggest that PSPs are positively associated with the prevalence of T2DM in women with a history of GDM, which demonstrates that we need targeted interventions, especially for those at high risk. Future research should evaluate how sleep patterns affect metabolic health and develop new ways to lower the risk of T2DM in women with a history of GDM.
- Open Access
- 1 March 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 923-935
Endometriosis Severity and Risk of Preeclampsia: A Combined Mendelian Randomization and Observational Study
Purpose: Endometriosis has been hypothesized to increase the risk of preeclampsia (PE) and eclampsia, although the exact mechanism of this relationship is not clear. This study aimed to further explore the potential association between endometriosis and PE/eclampsia through Mendelian randomization (MR) and confirm these findings in a retrospective cohort study. Methods: A two-sample MR study was performed using genetic variants associated with endometriosis from the Finnish database, with outcome data for PE and eclampsia from the UK Biobank. Subgroup analyses were conducted based on endometriosis severity (American society of reproductive Medicine (ASRM) stages I–II and III–IV) and anatomical location (uterus, ovary, deep infiltrating endometriosis). Additionally, a retrospective cohort study was conducted to further assess the association, adjusting for confounding factors such as age, Body Mass Index (BMI), dysmenorrhea, history of uterine surgery, and adenomyosis. Multivariate logistic regression was used to analyze the risk of PE/eclampsia based on endometriosis severity. Results: MR using the Inverse Variance Weighted method found a meaningful association between advanced endometriosis (ASRM stages III–IV) and PE/eclampsia (p = 0.008), while no significant associations were observed for lower stages or endometriosis in the uterus and ovary. In the retrospective cohort, the initial association between the revised American Fertility Society (r-AFS) score and PE/eclampsia (OR: 1.02, 95% CI: 1.01– 1.03, p < 0.001) weakened after adjusting for confounders. Significant risk factors identified included age (OR: 1.20, 95% CI: 1.10– 1.30, p < 0.001), dysmenorrhea (OR: 2.72, 95% CI: 1.31– 5.76, p = 0.008) and adenomyosis showing the strongest association (OR: 9.96, 95% CI: 5.00– 20.06, p < 0.001). Conclusion: The findings suggest a potential relationship between advanced endometriosis and the risk of PE/eclampsia. However, other clinical factors such as age, dysmenorrhea, and adenomyosis appear to contribute more significantly to the risk. Further studies are needed to confirm these findings and clarify the underlying mechanisms.
- 1 March 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 923-935
Open AccessEndometriosis Severity and Risk of Preeclampsia: A Combined Mendelian Randomization and Observational Study
Purpose: Endometriosis has been hypothesized to increase the risk of preeclampsia (PE) and eclampsia, although the exact mechanism of this relationship is not clear. This study aimed to further explore the potential association between endometriosis and PE/eclampsia through Mendelian randomization (MR) and confirm these findings in a retrospective cohort study. Methods: A two-sample MR study was performed using genetic variants associated with endometriosis from the Finnish database, with outcome data for PE and eclampsia from the UK Biobank. Subgroup analyses were conducted based on endometriosis severity (American society of reproductive Medicine (ASRM) stages I–II and III–IV) and anatomical location (uterus, ovary, deep infiltrating endometriosis). Additionally, a retrospective cohort study was conducted to further assess the association, adjusting for confounding factors such as age, Body Mass Index (BMI), dysmenorrhea, history of uterine surgery, and adenomyosis. Multivariate logistic regression was used to analyze the risk of PE/eclampsia based on endometriosis severity. Results: MR using the Inverse Variance Weighted method found a meaningful association between advanced endometriosis (ASRM stages III–IV) and PE/eclampsia (p = 0.008), while no significant associations were observed for lower stages or endometriosis in the uterus and ovary. In the retrospective cohort, the initial association between the revised American Fertility Society (r-AFS) score and PE/eclampsia (OR: 1.02, 95% CI: 1.01– 1.03, p < 0.001) weakened after adjusting for confounders. Significant risk factors identified included age (OR: 1.20, 95% CI: 1.10– 1.30, p < 0.001), dysmenorrhea (OR: 2.72, 95% CI: 1.31– 5.76, p = 0.008) and adenomyosis showing the strongest association (OR: 9.96, 95% CI: 5.00– 20.06, p < 0.001). Conclusion: The findings suggest a potential relationship between advanced endometriosis and the risk of PE/eclampsia. However, other clinical factors such as age, dysmenorrhea, and adenomyosis appear to contribute more significantly to the risk. Further studies are needed to confirm these findings and clarify the underlying mechanisms.